1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Gene Amplification Technologies Market: About this market
The gene amplification technologies market analysis considers sales from medical and pharmaceutical, forensic and identity testing, agricultural and food safety, and other applications. Our analysis also considers the sales of gene amplification technologies in Asia, Europe, North America, and ROW. In 2018, the medical and pharmaceutical segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising prevalence of genetic and infectious conditions and the growing need for drug discovery will play a significant role in the medical and pharmaceutical segment to maintain its market position. Also, our global gene amplification technologies market report looks at factors such as increasing genomic research, substantial adoption of gene amplification technologies in targeted cancer therapies, and low cost of genetic sequencing. However, varying regulatory guidelines on genetic research and testing, requirement for high expertise to perform gene amplification studies, and increasing number of product recalls may hamper the growth of the gene amplification technologies industry over the forecast period.
Global Gene Amplification Technologies Market: Overview
Adoption of gene amplification kits in targeted cancer therapies is being witnessed due to the increasing demand for alternative treatments to chemotherapy. This is also due to the increase in approvals for targeted gene therapies by regulatory authorities. Thus, the increasing development of such therapies to treat various cancers, such as colorectal, cervical, and breast cancer, is expected to trigger the adoption of gene amplification technologies and lead to the expansion of the global gene amplification technologies market at a CAGR of over 9% during the forecast period.
Rising demand for gene amplification kits and assays in consumer genetics
Genetic testing for the identification of disease risks and paternity is performed by reference laboratories using gene multiplexing techniques that involve the use of gene amplification kits and assays. The rising popularity of relationship testing services, such as ancestry testing and paternity testing, has resulted in the high adoption of consumer genetic services, specifically among the millennial population. The demand for determining the risk of cancers through genetic tests has increased due to the rising mortality rates associated with cancers. This has promoted the use of dedicated gene amplification kits in direct-to-consumer testing for cancer risk analyses. These factors are expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global gene amplification technologies market is moderately fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene amplification technologies manufacturers, that include Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN Group, Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Also, the gene amplification technologies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The gene amplification technologies market analysis considers sales from medical and pharmaceutical, forensic and identity testing, agricultural and food safety, and other applications. Our analysis also considers the sales of gene amplification technologies in Asia, Europe, North America, and ROW. In 2018, the medical and pharmaceutical segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising prevalence of genetic and infectious conditions and the growing need for drug discovery will play a significant role in the medical and pharmaceutical segment to maintain its market position. Also, our global gene amplification technologies market report looks at factors such as increasing genomic research, substantial adoption of gene amplification technologies in targeted cancer therapies, and low cost of genetic sequencing. However, varying regulatory guidelines on genetic research and testing, requirement for high expertise to perform gene amplification studies, and increasing number of product recalls may hamper the growth of the gene amplification technologies industry over the forecast period.
Global Gene Amplification Technologies Market: Overview
Adoption of gene amplification kits in targeted cancer therapies is being witnessed due to the increasing demand for alternative treatments to chemotherapy. This is also due to the increase in approvals for targeted gene therapies by regulatory authorities. Thus, the increasing development of such therapies to treat various cancers, such as colorectal, cervical, and breast cancer, is expected to trigger the adoption of gene amplification technologies and lead to the expansion of the global gene amplification technologies market at a CAGR of over 9% during the forecast period.
Rising demand for gene amplification kits and assays in consumer genetics
Genetic testing for the identification of disease risks and paternity is performed by reference laboratories using gene multiplexing techniques that involve the use of gene amplification kits and assays. The rising popularity of relationship testing services, such as ancestry testing and paternity testing, has resulted in the high adoption of consumer genetic services, specifically among the millennial population. The demand for determining the risk of cancers through genetic tests has increased due to the rising mortality rates associated with cancers. This has promoted the use of dedicated gene amplification kits in direct-to-consumer testing for cancer risk analyses. These factors are expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global gene amplification technologies market is moderately fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene amplification technologies manufacturers, that include Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN Group, Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Also, the gene amplification technologies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
PART 01: EXECUTIVE SUMMARYPART 07: CUSTOMER LANDSCAPEPART 09: DECISION FRAMEWORK
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY APPLICATION
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
The following companies are recognised as the key players in the global gene amplification technologies market: Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN Group, Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rising demand for gene amplification kits and assays in consumer genetics.”
According to the report, one of the major drivers for this market is the substantial adoption of gene amplification technologies in targeted cancer therapies.
Further, the report states that one of the major factors hindering the growth of this market is the requirement for high expertise to perform gene amplification studies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rising demand for gene amplification kits and assays in consumer genetics.”
According to the report, one of the major drivers for this market is the substantial adoption of gene amplification technologies in targeted cancer therapies.
Further, the report states that one of the major factors hindering the growth of this market is the requirement for high expertise to perform gene amplification studies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- PerkinElmer Inc.
- QIAGEN Group
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
